Amphastar Pharmaceuticals (AMPH) Construction in Progress (2013 - 2015)

Amphastar Pharmaceuticals' Construction in Progress history runs 3 years deep, the most recent figure standing at $29.5 million for Q2 2015.

• On a quarterly basis, Construction in Progress rose 49.01% year-over-year to $29.5 million in Q2 2015; TTM through Jun 2015 was $29.5 million, a 49.01% increase from a year earlier, with the FY2014 full-year figure at $25.1 million, up 59.82% from the prior year.
• Construction in Progress grew to $29.5 million in Q2 2015 per AMPH's latest filing, from $28.5 million in the prior quarter.
• Across five years, Construction in Progress topped out at $29.5 million in Q2 2015 and bottomed at $15.7 million in Q4 2013.
• The 3-year median for Construction in Progress is $22.7 million (2014), against an average of $23.1 million.
• Across the five-year window, Construction in Progress jumped 59.82% in 2014 and soared 49.01% in 2015, its largest moves.
• Year by year, Construction in Progress stood at $15.7 million in 2013, then soared by 59.82% to $25.1 million in 2014, then increased by 17.69% to $29.5 million in 2015.
• Per Business Quant, the three latest AMPH Construction in Progress figures stand at $29.5 million (Q2 2015), $28.5 million (Q1 2015), and $25.1 million (Q4 2014).